Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

A mini-review on platelet refractoriness.

Rebulla P.

Haematologica. 2005 Feb;90(2):247-53. Review.

2.
3.

Clinical aspects of platelet transfusions.

Murphy MF, Waters AH.

Blood Coagul Fibrinolysis. 1991 Apr;2(2):389-96. Review.

PMID:
1893071
4.

Use of HLA- and HPA--matched platelets in alloimmunized patients.

Kekomäki R.

Vox Sang. 1998;74 Suppl 2:359-63. Review.

PMID:
9704468
5.

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.

Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM.

Transfusion. 2000 Dec;40(12):1446-56.

PMID:
11134563
6.

The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.

Benson K, Fields K, Hiemenz J, Zorsky P, Ballester O, Perkins J, Elfenbein G.

Semin Oncol. 1993 Oct;20(5 Suppl 6):102-9. Review.

PMID:
8211211
7.

Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force.

Murphy MF, Brozovic B, Murphy W, Ouwehand W, Waters AH.

Transfus Med. 1992 Dec;2(4):311-8.

PMID:
1339584
8.

Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.

Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG.

Transfusion. 1995 Aug;35(8):645-52.

PMID:
7631404
9.

Platelet transfusions: the problem of refractoriness.

Murphy MF, Waters AH.

Blood Rev. 1990 Mar;4(1):16-24. Review.

PMID:
2182145
10.

[Platelet transfusion refractoriness and effective management of platelet alloimmunization].

Amemiya Y.

Nihon Rinsho. 1997 Sep;55(9):2392-8. Review. Japanese.

PMID:
9301306
11.
12.

Establishment of platelet donor registry improves the treatment of platelet transfusion refractoriness in Guangzhou region of China.

Xia WJ, Ye X, Tian LW, Xu XZ, Chen YK, Luo GP, Bei CH, Deng J, Santoso S, Fu YS.

Transfus Med. 2010 Aug 1;20(4):269-74. doi: 10.1111/j.1365-3148.2010.00995.x. Epub 2010 Feb 4.

PMID:
20136782
13.

Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates.

O'Connell BA, Lee EJ, Rothko K, Hussein MA, Schiffer CA.

Blood. 1992 Jan 15;79(2):527-31.

14.

Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.

Duquesnoy RJ, Filip DJ, Rodey GE, Rimm AA, Aster RH.

Am J Hematol. 1977;2(3):219-26.

PMID:
596366
15.
16.

The alloimmunized patient: effective transfusion support and newer experimental approaches.

Pamphilon DH.

Blood Coagul Fibrinolysis. 1992 Oct;3(5):651-4. Review.

PMID:
1450334
17.
18.

Management of patients refractory to platelet transfusion.

Chockalingam P, Sacher RA.

J Infus Nurs. 2007 Jul-Aug;30(4):220-5. Review.

PMID:
17667077
19.

Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products.

Rebulla P, Morelati F, Revelli N, Villa MA, Paccapelo C, Nocco A, Greppi N, Marconi M, Cortelezzi A, Fracchiolla N, Martinelli G, Deliliers GL.

Br J Haematol. 2004 Apr;125(1):83-9.

PMID:
15015974
20.

[Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].

Pereira J, Bronfman L, Bertín P, Marzouka E, Hidalgo P, Amaya S, Mezzano D.

Rev Med Chil. 1997 Nov;125(11):1305-12. Spanish.

PMID:
9609051
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk